A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery

Clinical trial NCT05457842 · TERMINATED

Trial details

NCT number: NCT05457842
Sponsor: Astellas Pharma Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sentinel Lymph Node Biopsy Breast Cancer Melanoma

Start date: 2022-08-10
Primary completion: 2022-09-02
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.